US Stock MarketDetailed Quotes
VRPX Virpax Pharmaceuticals
- 0.8490
- 0.00000.00%
Close Aug 14 16:00 ET
- 0.8500
- +0.0010+0.12%
Post 20:02 ET
4.15MMarket Cap-64P/E (TTM)
0.8500High0.8233Low81.99KVolume0.8260Open0.8490Pre Close68.80KTurnover1.79%Turnover RatioLossP/E (Static)4.89MShares9.500052wk High-1.48P/B3.89MFloat Cap0.460352wk Low--Dividend TTM4.59MShs Float360.0000Historical High--Div YieldTTM3.15%Amplitude0.4600Historical Low0.8390Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
Virpax Pharmaceuticals Stock Forum
https://x.com/VirpaxPharma/status/1820516904324489384?t=391j5q1D-NXm_XZGFBAeIQ&s=19
The offering is expected to close one business day following its commencement. Virpax intends to use the net proceeds from the offering to fund ongoing activities related to their planned Investigational New Drug (IND) filing for Probudur, as well as for working capital and other general corporate purposes.
$Virpax Pharmaceuticals (VRPX.US)$ has been much more stable and has a better future by the looks with progress and news recently... time for me to jump off $Greenwave Technology Solutions (GWAV.US)$ and $GameStop (GME.US)$ and buy some more $Virpax Pharmaceuticals (VRPX.US)$ 💪
oh also I forgot to mention GO Trump $Trump Media & Technology (DJT.US)$ in 2024 🇺🇸
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) has successfully regained compliance with the minimum bid price requirement as mandated by The Nasdaq Stock Market LLC. This accomplishment is a milestone for the company, known for its focus on developing non-addictive products tailored for pain management, post-traumatic stress disorder, central nervous system disorders, and anti-...
No comment yet